Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CI | Common Stock, $.01 Par Value | Award | $0 | +3.82K | +8.94% | $0.00 | 46.6K | Feb 25, 2022 | Direct | F1 |
transaction | CI | Common Stock, $.01 Par Value | Tax liability | -$192K | -837 | -1.8% | $229.64 | 45.8K | Feb 25, 2022 | Direct | F2 |
transaction | CI | Common Stock, $.01 Par Value | Tax liability | -$348K | -1.52K | -3.31% | $229.64 | 44.2K | Feb 25, 2022 | Direct | F3 |
transaction | CI | Common Stock, $.01 Par Value | Sale | -$528K | -2.31K | -5.21% | $228.70 | 41.9K | Feb 28, 2022 | Direct | F4 |
holding | CI | Common Stock, $.01 Par Value | 1.34K | Feb 25, 2022 | By 401(k) | F5 |
Id | Content |
---|---|
F1 | The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2019-2021 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
F2 | Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
F3 | Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
F4 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021. |
F5 | Represents shares acquired through ongoing participation in Cigna's 401(k) Plan. |